Overview

Endothelial Dysfunction in Subjects With History of Premature Coronary Artery Disease

Status:
Unknown status
Trial end date:
2013-06-01
Target enrollment:
0
Participant gender:
All
Summary
The aim of this prospective study is to investigate the prevalence of endothelial dysfunction in subjects with family history of premature coronary heart disease. At the same time, the effect of atorvastatin in treating subclinical endothelial dysfunction in those patients will be evaluated.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Yonsei University
Treatments:
Atorvastatin
Atorvastatin Calcium
Criteria
Inclusion Criteria:

- within 1 year

- the siblings of premature coronary heart disease(male<55years old, female<65years old:
Framingham Heart Study)patients admitted relevant hospital

Exclusion Criteria:

- Documented coronary heart disease

- Any woman of childbearing potential who is pregnant, seeking to become pregnant or
suspects that she may be pregnant.